id	sid	tid	token	lemma	pos
dpc-2817	1	1	dermatology	dermatology	NOUN
dpc-2817	1	2	:	:	PUNCT
dpc-2817	1	3	practical	practical	ADJ
dpc-2817	1	4	and	and	CCONJ
dpc-2817	1	5	conceptual	conceptual	ADJ
dpc-2817	1	6	image	image	NOUN
dpc-2817	1	7	letter	letter	NOUN
dpc-2817	2	1	|	|	ADV
dpc-2817	2	2	dermatol	dermatol	ADJ
dpc-2817	2	3	pract	pract	NOUN
dpc-2817	2	4	concept	concept	NOUN
dpc-2817	2	5	.	.	PUNCT
dpc-2817	3	1	2023;13(2):e2023111	2023;13(2):e2023111	NUM
dpc-2817	3	2	1	1	NUM
dpc-2817	3	3	violaceous	violaceous	ADJ
dpc-2817	3	4	macules	macule	NOUN
dpc-2817	3	5	on	on	ADP
dpc-2817	3	6	the	the	DET
dpc-2817	3	7	auricles	auricle	NOUN
dpc-2817	3	8	:	:	PUNCT
dpc-2817	3	9	a	a	DET
dpc-2817	3	10	clinical	clinical	ADJ
dpc-2817	3	11	sign	sign	NOUN
dpc-2817	3	12	of	of	ADP
dpc-2817	3	13	dermatomyositis	dermatomyositis	PROPN
dpc-2817	3	14	lluís	lluís	PROPN
dpc-2817	3	15	corbella	corbella	PROPN
dpc-2817	3	16	-	-	PUNCT
dpc-2817	3	17	bagot1	bagot1	PROPN
dpc-2817	3	18	,	,	PUNCT
dpc-2817	3	19	francesc	francesc	NOUN
dpc-2817	3	20	alamon	alamon	PROPN
dpc-2817	3	21	-	-	PUNCT
dpc-2817	3	22	reig1	reig1	PROPN
dpc-2817	3	23	,	,	PUNCT
dpc-2817	3	24	daniel	daniel	PROPN
dpc-2817	3	25	morgado	morgado	PROPN
dpc-2817	3	26	-	-	PUNCT
dpc-2817	3	27	carrasco1	carrasco1	ADJ
dpc-2817	3	28	1	1	NUM
dpc-2817	3	29	department	department	NOUN
dpc-2817	3	30	of	of	ADP
dpc-2817	3	31	dermatology	dermatology	NOUN
dpc-2817	3	32	,	,	PUNCT
dpc-2817	3	33	hospital	hospital	NOUN
dpc-2817	3	34	clínic	clínic	PROPN
dpc-2817	3	35	de	de	PROPN
dpc-2817	3	36	barcelona	barcelona	PROPN
dpc-2817	3	37	,	,	PUNCT
dpc-2817	3	38	university	university	PROPN
dpc-2817	3	39	of	of	ADP
dpc-2817	3	40	barcelona	barcelona	PROPN
dpc-2817	3	41	,	,	PUNCT
dpc-2817	3	42	barcelona	barcelona	PROPN
dpc-2817	3	43	,	,	PUNCT
dpc-2817	3	44	spain	spain	PROPN
dpc-2817	3	45	citation	citation	PROPN
dpc-2817	3	46	:	:	PUNCT
dpc-2817	3	47	corbella	corbella	NOUN
dpc-2817	3	48	-	-	PUNCT
dpc-2817	3	49	bagot	bagot	PROPN
dpc-2817	3	50	l	l	PROPN
dpc-2817	3	51	,	,	PUNCT
dpc-2817	3	52	alamon	alamon	NOUN
dpc-2817	3	53	-	-	PUNCT
dpc-2817	3	54	reig	reig	PROPN
dpc-2817	3	55	f	f	NUM
dpc-2817	3	56	,	,	PUNCT
dpc-2817	3	57	morgado	morgado	PROPN
dpc-2817	3	58	-	-	PUNCT
dpc-2817	3	59	carrasco	carrasco	PROPN
dpc-2817	3	60	d.	d.	PROPN
dpc-2817	3	61	violaceous	violaceous	PROPN
dpc-2817	3	62	macules	macule	NOUN
dpc-2817	3	63	on	on	ADP
dpc-2817	3	64	the	the	DET
dpc-2817	3	65	auricles	auricle	NOUN
dpc-2817	3	66	:	:	PUNCT
dpc-2817	3	67	a	a	DET
dpc-2817	3	68	clinical	clinical	ADJ
dpc-2817	3	69	sign	sign	NOUN
dpc-2817	3	70	of	of	ADP
dpc-2817	3	71	dermatomyositis	dermatomyositis	PROPN
dpc-2817	3	72	.	.	PUNCT
dpc-2817	4	1	dermatol	dermatol	NOUN
dpc-2817	4	2	pract	pract	PROPN
dpc-2817	4	3	concept	concept	NOUN
dpc-2817	4	4	.	.	PUNCT
dpc-2817	5	1	2023;13(2):e2023111	2023;13(2):e2023111	X
dpc-2817	5	2	.	.	PUNCT
dpc-2817	5	3	doi	doi	PROPN
dpc-2817	5	4	:	:	PUNCT
dpc-2817	5	5	https://doi.org/10.5826/dpc.1302a111	https://doi.org/10.5826/dpc.1302a111	PROPN
dpc-2817	5	6	accepted	accept	VERB
dpc-2817	5	7	:	:	PUNCT
dpc-2817	5	8	october	october	PROPN
dpc-2817	5	9	26	26	NUM
dpc-2817	5	10	,	,	PUNCT
dpc-2817	5	11	2022	2022	NUM
dpc-2817	5	12	;	;	PUNCT
dpc-2817	5	13	published	publish	VERB
dpc-2817	5	14	:	:	PUNCT
dpc-2817	6	1	april	april	PROPN
dpc-2817	6	2	2023	2023	NUM
dpc-2817	6	3	copyright	copyright	NOUN
dpc-2817	6	4	:	:	PUNCT
dpc-2817	6	5	©	©	PROPN
dpc-2817	6	6	2023	2023	NUM
dpc-2817	6	7	corbella	corbella	NOUN
dpc-2817	6	8	-	-	PUNCT
dpc-2817	6	9	bagot	bagot	PROPN
dpc-2817	6	10	et	et	PROPN
dpc-2817	6	11	al	al	PROPN
dpc-2817	6	12	.	.	PUNCT
dpc-2817	7	1	this	this	PRON
dpc-2817	7	2	is	be	AUX
dpc-2817	7	3	an	an	DET
dpc-2817	7	4	open	open	ADJ
dpc-2817	7	5	-	-	PUNCT
dpc-2817	7	6	access	access	NOUN
dpc-2817	7	7	article	article	NOUN
dpc-2817	7	8	distributed	distribute	VERB
dpc-2817	7	9	under	under	ADP
dpc-2817	7	10	the	the	DET
dpc-2817	7	11	terms	term	NOUN
dpc-2817	7	12	of	of	ADP
dpc-2817	7	13	the	the	DET
dpc-2817	7	14	creative	creative	ADJ
dpc-2817	7	15	commons	common	NOUN
dpc-2817	7	16	attribution	attribution	NOUN
dpc-2817	7	17	-	-	PUNCT
dpc-2817	7	18	noncommercial	noncommercial	ADJ
dpc-2817	7	19	license	license	NOUN
dpc-2817	7	20	(	(	PUNCT
dpc-2817	7	21	by	by	ADP
dpc-2817	7	22	-	-	PUNCT
dpc-2817	7	23	nc-4.0	nc-4.0	NOUN
dpc-2817	7	24	)	)	PUNCT
dpc-2817	7	25	,	,	PUNCT
dpc-2817	7	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2817	7	27	,	,	PUNCT
dpc-2817	7	28	which	which	PRON
dpc-2817	7	29	permits	permit	VERB
dpc-2817	7	30	unrestricted	unrestricted	ADJ
dpc-2817	7	31	noncommercial	noncommercial	ADJ
dpc-2817	7	32	use	use	NOUN
dpc-2817	7	33	,	,	PUNCT
dpc-2817	7	34	distribution	distribution	NOUN
dpc-2817	7	35	,	,	PUNCT
dpc-2817	7	36	and	and	CCONJ
dpc-2817	7	37	reproduction	reproduction	NOUN
dpc-2817	7	38	in	in	ADP
dpc-2817	7	39	any	any	DET
dpc-2817	7	40	medium	medium	NOUN
dpc-2817	7	41	,	,	PUNCT
dpc-2817	7	42	provided	provide	VERB
dpc-2817	7	43	the	the	DET
dpc-2817	7	44	original	original	ADJ
dpc-2817	7	45	authors	author	NOUN
dpc-2817	7	46	and	and	CCONJ
dpc-2817	7	47	source	source	NOUN
dpc-2817	7	48	are	be	AUX
dpc-2817	7	49	credited	credit	VERB
dpc-2817	7	50	.	.	PUNCT
dpc-2817	8	1	funding	funding	NOUN
dpc-2817	8	2	:	:	PUNCT
dpc-2817	8	3	none	none	NOUN
dpc-2817	8	4	.	.	PUNCT
dpc-2817	9	1	competing	compete	VERB
dpc-2817	9	2	interests	interest	NOUN
dpc-2817	9	3	:	:	PUNCT
dpc-2817	9	4	none	none	NOUN
dpc-2817	9	5	.	.	PUNCT
dpc-2817	10	1	authorship	authorship	NOUN
dpc-2817	10	2	:	:	PUNCT
dpc-2817	10	3	all	all	DET
dpc-2817	10	4	authors	author	NOUN
dpc-2817	10	5	have	have	AUX
dpc-2817	10	6	contributed	contribute	VERB
dpc-2817	10	7	significantly	significantly	ADV
dpc-2817	10	8	to	to	ADP
dpc-2817	10	9	this	this	DET
dpc-2817	10	10	publication	publication	NOUN
dpc-2817	10	11	.	.	PUNCT
dpc-2817	11	1	corresponding	correspond	VERB
dpc-2817	11	2	author	author	NOUN
dpc-2817	11	3	:	:	PUNCT
dpc-2817	11	4	daniel	daniel	PROPN
dpc-2817	11	5	morgado	morgado	PROPN
dpc-2817	11	6	-	-	PUNCT
dpc-2817	11	7	carrasco	carrasco	PROPN
dpc-2817	11	8	,	,	PUNCT
dpc-2817	11	9	dermatology	dermatology	NOUN
dpc-2817	11	10	department	department	NOUN
dpc-2817	11	11	,	,	PUNCT
dpc-2817	11	12	hospital	hospital	NOUN
dpc-2817	11	13	clínic	clínic	PROPN
dpc-2817	11	14	de	de	PROPN
dpc-2817	11	15	barcelona	barcelona	PROPN
dpc-2817	11	16	,	,	PUNCT
dpc-2817	11	17	c/	c/	NOUN
dpc-2817	11	18	villarroel	villarroel	PROPN
dpc-2817	11	19	,	,	PUNCT
dpc-2817	11	20	170	170	NUM
dpc-2817	11	21	,	,	PUNCT
dpc-2817	11	22	08036	08036	NUM
dpc-2817	11	23	,	,	PUNCT
dpc-2817	11	24	barcelona	barcelona	PROPN
dpc-2817	11	25	,	,	PUNCT
dpc-2817	11	26	spain	spain	PROPN
dpc-2817	11	27	.	.	PUNCT
dpc-2817	12	1	tel	tel	ADP
dpc-2817	12	2	:	:	PUNCT
dpc-2817	12	3	(	(	PUNCT
dpc-2817	12	4	+34	+34	ADJ
dpc-2817	12	5	)	)	PUNCT
dpc-2817	12	6	93	93	NUM
dpc-2817	12	7	227	227	NUM
dpc-2817	12	8	54	54	NUM
dpc-2817	12	9	00	00	NUM
dpc-2817	12	10	;	;	PUNCT
dpc-2817	12	11	fax	fax	NOUN
dpc-2817	12	12	:	:	PUNCT
dpc-2817	12	13	(	(	PUNCT
dpc-2817	12	14	+34	+34	ADJ
dpc-2817	12	15	)	)	PUNCT
dpc-2817	12	16	932275438	932275438	NUM
dpc-2817	13	1	e	e	NOUN
dpc-2817	13	2	-	-	NOUN
dpc-2817	13	3	mail	mail	NOUN
dpc-2817	13	4	:	:	PUNCT
dpc-2817	13	5	morgadodaniel8@gmail.com	morgadodaniel8@gmail.com	X
dpc-2817	13	6	case	case	NOUN
dpc-2817	13	7	presentation	presentation	NOUN
dpc-2817	13	8	a	a	DET
dpc-2817	13	9	66	66	NUM
dpc-2817	13	10	-	-	PUNCT
dpc-2817	13	11	year	year	NOUN
dpc-2817	13	12	-	-	PUNCT
dpc-2817	13	13	old	old	ADJ
dpc-2817	13	14	male	male	NOUN
dpc-2817	13	15	with	with	ADP
dpc-2817	13	16	a	a	DET
dpc-2817	13	17	recently	recently	ADV
dpc-2817	13	18	diagnosed	diagnose	VERB
dpc-2817	13	19	metastatic	metastatic	ADJ
dpc-2817	13	20	bladder	bladder	NOUN
dpc-2817	13	21	carcinoma	carcinoma	NOUN
dpc-2817	13	22	presented	present	VERB
dpc-2817	13	23	with	with	ADP
dpc-2817	13	24	muscle	muscle	NOUN
dpc-2817	13	25	weakness	weakness	NOUN
dpc-2817	13	26	and	and	CCONJ
dpc-2817	13	27	generalized	generalized	ADJ
dpc-2817	13	28	pruritic	pruritic	ADJ
dpc-2817	13	29	rash	rash	NOUN
dpc-2817	13	30	.	.	PUNCT
dpc-2817	14	1	physical	physical	ADJ
dpc-2817	14	2	examination	examination	NOUN
dpc-2817	14	3	revealed	reveal	VERB
dpc-2817	14	4	heliotrope	heliotrope	PROPN
dpc-2817	14	5	erythema	erythema	PROPN
dpc-2817	14	6	,	,	PUNCT
dpc-2817	14	7	v	v	NOUN
dpc-2817	14	8	-	-	PUNCT
dpc-2817	14	9	neck	neck	NOUN
dpc-2817	14	10	sign	sign	NOUN
dpc-2817	14	11	,	,	PUNCT
dpc-2817	14	12	shawl	shawl	NOUN
dpc-2817	14	13	sign	sign	NOUN
dpc-2817	14	14	,	,	PUNCT
dpc-2817	14	15	gottron	gottron	VERB
dpc-2817	14	16	papules	papule	NOUN
dpc-2817	14	17	and	and	CCONJ
dpc-2817	14	18	dilated	dilate	VERB
dpc-2817	14	19	nailfold	nailfold	ADJ
dpc-2817	14	20	capillary	capillary	ADJ
dpc-2817	14	21	loops	loop	NOUN
dpc-2817	14	22	.	.	PUNCT
dpc-2817	15	1	interestingly	interestingly	ADV
dpc-2817	15	2	,	,	PUNCT
dpc-2817	15	3	several	several	ADJ
dpc-2817	15	4	purpuric	purpuric	ADJ
dpc-2817	15	5	macules	macule	NOUN
dpc-2817	15	6	,	,	PUNCT
dpc-2817	15	7	together	together	ADV
dpc-2817	15	8	with	with	ADP
dpc-2817	15	9	ulcers	ulcer	NOUN
dpc-2817	15	10	and	and	CCONJ
dpc-2817	15	11	crusting	crust	VERB
dpc-2817	15	12	were	be	AUX
dpc-2817	15	13	observed	observe	VERB
dpc-2817	15	14	in	in	ADP
dpc-2817	15	15	both	both	DET
dpc-2817	15	16	auricles	auricle	NOUN
dpc-2817	15	17	(	(	PUNCT
dpc-2817	15	18	figure	figure	NOUN
dpc-2817	15	19	1	1	NUM
dpc-2817	15	20	)	)	PUNCT
dpc-2817	15	21	.	.	PUNCT
dpc-2817	16	1	blood	blood	NOUN
dpc-2817	16	2	tests	test	NOUN
dpc-2817	16	3	showed	show	VERB
dpc-2817	16	4	high	high	ADJ
dpc-2817	16	5	muscle	muscle	NOUN
dpc-2817	16	6	enzymes	enzyme	NOUN
dpc-2817	16	7	(	(	PUNCT
dpc-2817	16	8	creatine	creatine	PROPN
dpc-2817	16	9	-	-	PUNCT
dpc-2817	16	10	kinase	kinase	PROPN
dpc-2817	16	11	5954	5954	NUM
dpc-2817	16	12	u	u	NOUN
dpc-2817	16	13	/	/	SYM
dpc-2817	16	14	l	l	NOUN
dpc-2817	17	1	[	[	X
dpc-2817	17	2	normal	normal	ADJ
dpc-2817	17	3	value	value	NOUN
dpc-2817	17	4	<	<	X
dpc-2817	17	5	300	300	NUM
dpc-2817	17	6	u	u	NOUN
dpc-2817	17	7	/	/	SYM
dpc-2817	17	8	l	l	NOUN
dpc-2817	17	9	]	]	PUNCT
dpc-2817	17	10	and	and	CCONJ
dpc-2817	17	11	aldolase	aldolase	NOUN
dpc-2817	17	12	43.5	43.5	NUM
dpc-2817	17	13	u	u	NOUN
dpc-2817	17	14	/	/	SYM
dpc-2817	17	15	l	l	NOUN
dpc-2817	18	1	[	[	X
dpc-2817	18	2	normal	normal	ADJ
dpc-2817	18	3	range	range	VERB
dpc-2817	18	4	0.3	0.3	NUM
dpc-2817	18	5	-	-	SYM
dpc-2817	18	6	6.0	6.0	NUM
dpc-2817	18	7	u	u	NOUN
dpc-2817	18	8	/	/	SYM
dpc-2817	18	9	l	l	NOUN
dpc-2817	18	10	]	]	PUNCT
dpc-2817	18	11	)	)	PUNCT
dpc-2817	18	12	,	,	PUNCT
dpc-2817	18	13	and	and	CCONJ
dpc-2817	18	14	anti	anti	ADJ
dpc-2817	18	15	-	-	ADJ
dpc-2817	18	16	transcriptional	transcriptional	ADJ
dpc-2817	18	17	intermediary	intermediary	ADJ
dpc-2817	18	18	factor	factor	NOUN
dpc-2817	18	19	1	1	NUM
dpc-2817	18	20	gamma	gamma	NOUN
dpc-2817	18	21	(	(	PUNCT
dpc-2817	18	22	tif1	tif1	PROPN
dpc-2817	18	23	-	-	PUNCT
dpc-2817	18	24	γ	γ	NOUN
dpc-2817	18	25	)	)	PUNCT
dpc-2817	18	26	antibody	antibody	NOUN
dpc-2817	18	27	positivity	positivity	NOUN
dpc-2817	18	28	.	.	PUNCT
dpc-2817	19	1	the	the	DET
dpc-2817	19	2	remaining	remain	VERB
dpc-2817	19	3	myositis	myositis	NOUN
dpc-2817	19	4	-	-	PUNCT
dpc-2817	19	5	specific	specific	ADJ
dpc-2817	19	6	antibodies	antibody	NOUN
dpc-2817	19	7	were	be	AUX
dpc-2817	19	8	negative	negative	ADJ
dpc-2817	19	9	.	.	PUNCT
dpc-2817	20	1	skin	skin	NOUN
dpc-2817	20	2	and	and	CCONJ
dpc-2817	20	3	muscle	muscle	NOUN
dpc-2817	20	4	biopsies	biopsy	NOUN
dpc-2817	20	5	confirmed	confirm	VERB
dpc-2817	20	6	the	the	DET
dpc-2817	20	7	diagnosis	diagnosis	NOUN
dpc-2817	20	8	of	of	ADP
dpc-2817	20	9	dermatomyositis	dermatomyositis	PROPN
dpc-2817	20	10	.	.	PUNCT
dpc-2817	21	1	treatment	treatment	NOUN
dpc-2817	21	2	with	with	ADP
dpc-2817	21	3	prednisone	prednisone	NOUN
dpc-2817	21	4	120	120	NUM
dpc-2817	21	5	mg/	mg/	ADJ
dpc-2817	21	6	day	day	NOUN
dpc-2817	21	7	(	(	PUNCT
dpc-2817	21	8	1	1	NUM
dpc-2817	21	9	mg	mg	PROPN
dpc-2817	21	10	/	/	SYM
dpc-2817	21	11	kg	kg	PROPN
dpc-2817	21	12	/	/	SYM
dpc-2817	21	13	day	day	NOUN
dpc-2817	21	14	)	)	PUNCT
dpc-2817	21	15	and	and	CCONJ
dpc-2817	21	16	hydroxychloroquine	hydroxychloroquine	VERB
dpc-2817	21	17	400	400	NUM
dpc-2817	21	18	mg	mg	NUM
dpc-2817	21	19	/	/	SYM
dpc-2817	21	20	day	day	NOUN
dpc-2817	21	21	was	be	AUX
dpc-2817	21	22	initiated	initiate	VERB
dpc-2817	21	23	with	with	ADP
dpc-2817	21	24	progressive	progressive	ADJ
dpc-2817	21	25	improvement	improvement	NOUN
dpc-2817	21	26	of	of	ADP
dpc-2817	21	27	muscle	muscle	NOUN
dpc-2817	21	28	weakness	weakness	NOUN
dpc-2817	21	29	and	and	CCONJ
dpc-2817	21	30	cutaneous	cutaneous	ADJ
dpc-2817	21	31	involvement	involvement	NOUN
dpc-2817	21	32	.	.	PUNCT
dpc-2817	22	1	the	the	DET
dpc-2817	22	2	patient	patient	NOUN
dpc-2817	22	3	also	also	ADV
dpc-2817	22	4	started	start	VERB
dpc-2817	22	5	chemotherapy	chemotherapy	VERB
dpc-2817	22	6	with	with	ADP
dpc-2817	22	7	gemcitabine	gemcitabine	NOUN
dpc-2817	22	8	and	and	CCONJ
dpc-2817	22	9	cisplatin	cisplatin	NOUN
dpc-2817	22	10	and	and	CCONJ
dpc-2817	22	11	is	be	AUX
dpc-2817	22	12	currently	currently	ADV
dpc-2817	22	13	under	under	ADP
dpc-2817	22	14	follow	follow	NOUN
dpc-2817	22	15	-	-	PUNCT
dpc-2817	22	16	up	up	NOUN
dpc-2817	22	17	in	in	ADP
dpc-2817	22	18	the	the	DET
dpc-2817	22	19	oncology	oncology	NOUN
dpc-2817	22	20	and	and	CCONJ
dpc-2817	22	21	dermatology	dermatology	NOUN
dpc-2817	22	22	departments	department	NOUN
dpc-2817	22	23	.	.	PUNCT
dpc-2817	23	1	teaching	teaching	NOUN
dpc-2817	23	2	point	point	NOUN
dpc-2817	23	3	dermatomyositis	dermatomyositis	PROPN
dpc-2817	23	4	can	can	AUX
dpc-2817	23	5	present	present	VERB
dpc-2817	23	6	with	with	ADP
dpc-2817	23	7	a	a	DET
dpc-2817	23	8	myriad	myriad	NOUN
dpc-2817	23	9	of	of	ADP
dpc-2817	23	10	cutaneous	cutaneous	ADJ
dpc-2817	23	11	manifestations	manifestation	NOUN
dpc-2817	23	12	.	.	PUNCT
dpc-2817	24	1	violaceous	violaceous	ADJ
dpc-2817	24	2	macules	macule	NOUN
dpc-2817	24	3	on	on	ADP
dpc-2817	24	4	the	the	DET
dpc-2817	24	5	ears	ear	NOUN
dpc-2817	24	6	have	have	AUX
dpc-2817	24	7	recently	recently	ADV
dpc-2817	24	8	been	be	AUX
dpc-2817	24	9	described	describe	VERB
dpc-2817	24	10	in	in	ADP
dpc-2817	24	11	anti	anti	ADJ
dpc-2817	24	12	-	-	ADJ
dpc-2817	24	13	melanoma	melanoma	ADJ
dpc-2817	24	14	differentiation	differentiation	NOUN
dpc-2817	24	15	-	-	PUNCT
dpc-2817	24	16	associated	associate	VERB
dpc-2817	24	17	gene	gene	NOUN
dpc-2817	24	18	5	5	NUM
dpc-2817	24	19	(	(	PUNCT
dpc-2817	24	20	mda-5	mda-5	X
dpc-2817	24	21	)	)	PUNCT
dpc-2817	24	22	dermatomyositis	dermatomyositis	NOUN
dpc-2817	24	23	and	and	CCONJ
dpc-2817	24	24	may	may	AUX
dpc-2817	24	25	correlate	correlate	VERB
dpc-2817	24	26	with	with	ADP
dpc-2817	24	27	a	a	DET
dpc-2817	24	28	poor	poor	ADJ
dpc-2817	24	29	prognosis	prognosis	NOUN
dpc-2817	24	30	[	[	X
dpc-2817	24	31	1	1	NUM
dpc-2817	24	32	]	]	PUNCT
dpc-2817	24	33	.	.	PUNCT
dpc-2817	25	1	as	as	SCONJ
dpc-2817	25	2	the	the	DET
dpc-2817	25	3	violaceous	violaceous	ADJ
dpc-2817	25	4	macules	macule	NOUN
dpc-2817	25	5	and	and	CCONJ
dpc-2817	25	6	ulcers	ulcer	NOUN
dpc-2817	25	7	are	be	AUX
dpc-2817	25	8	predominantly	predominantly	ADV
dpc-2817	25	9	located	locate	VERB
dpc-2817	25	10	in	in	ADP
dpc-2817	25	11	anatomic	anatomic	ADJ
dpc-2817	25	12	protuberances	protuberance	NOUN
dpc-2817	25	13	in	in	ADP
dpc-2817	25	14	the	the	DET
dpc-2817	25	15	auricle	auricle	NOUN
dpc-2817	25	16	,	,	PUNCT
dpc-2817	25	17	a	a	DET
dpc-2817	25	18	pressure	pressure	NOUN
dpc-2817	25	19	-	-	PUNCT
dpc-2817	25	20	induced	induce	VERB
dpc-2817	25	21	microangiopathy	microangiopathy	NOUN
dpc-2817	25	22	has	have	AUX
dpc-2817	25	23	been	be	AUX
dpc-2817	25	24	proposed	propose	VERB
dpc-2817	25	25	as	as	ADP
dpc-2817	25	26	the	the	DET
dpc-2817	25	27	pathogenic	pathogenic	ADJ
dpc-2817	25	28	mechanism	mechanism	NOUN
dpc-2817	25	29	[	[	X
dpc-2817	25	30	2	2	NUM
dpc-2817	25	31	]	]	PUNCT
dpc-2817	25	32	.	.	PUNCT
dpc-2817	26	1	we	we	PRON
dpc-2817	26	2	have	have	AUX
dpc-2817	26	3	not	not	PART
dpc-2817	26	4	found	find	VERB
dpc-2817	26	5	any	any	DET
dpc-2817	26	6	described	describe	VERB
dpc-2817	26	7	case	case	NOUN
dpc-2817	26	8	presenting	present	VERB
dpc-2817	26	9	with	with	ADP
dpc-2817	26	10	positive	positive	ADJ
dpc-2817	26	11	anti	anti	ADJ
dpc-2817	26	12	-	-	ADJ
dpc-2817	26	13	tif1	tif1	NOUN
dpc-2817	26	14	-	-	PUNCT
dpc-2817	26	15	γ	γ	NOUN
dpc-2817	26	16	antibodies	antibodie	VERB
dpc-2817	26	17	,	,	PUNCT
dpc-2817	26	18	which	which	PRON
dpc-2817	26	19	have	have	AUX
dpc-2817	26	20	been	be	AUX
dpc-2817	26	21	associated	associate	VERB
dpc-2817	26	22	with	with	ADP
dpc-2817	26	23	malignancies	malignancy	NOUN
dpc-2817	26	24	.	.	PUNCT
dpc-2817	27	1	we	we	PRON
dpc-2817	27	2	report	report	VERB
dpc-2817	27	3	a	a	DET
dpc-2817	27	4	case	case	NOUN
dpc-2817	27	5	of	of	ADP
dpc-2817	27	6	a	a	DET
dpc-2817	27	7	paraneoplastic	paraneoplastic	ADJ
dpc-2817	27	8	anti	anti	ADJ
dpc-2817	27	9	-	-	ADJ
dpc-2817	27	10	tif1	tif1	NOUN
dpc-2817	27	11	-	-	PUNCT
dpc-2817	27	12	γ	γ	X
dpc-2817	27	13	positive	positive	ADJ
dpc-2817	27	14	dermatomyositis	dermatomyositis	NOUN
dpc-2817	27	15	presenting	present	VERB
dpc-2817	27	16	with	with	ADP
dpc-2817	27	17	violaceous	violaceous	ADJ
dpc-2817	27	18	macules	macule	NOUN
dpc-2817	27	19	in	in	ADP
dpc-2817	27	20	both	both	DET
dpc-2817	27	21	auricles	auricle	NOUN
dpc-2817	27	22	.	.	PUNCT
dpc-2817	28	1	clinicians	clinician	NOUN
dpc-2817	28	2	should	should	AUX
dpc-2817	28	3	be	be	AUX
dpc-2817	28	4	aware	aware	ADJ
dpc-2817	28	5	of	of	ADP
dpc-2817	28	6	this	this	DET
dpc-2817	28	7	recently	recently	ADV
dpc-2817	28	8	described	describe	VERB
dpc-2817	28	9	clinical	clinical	ADJ
dpc-2817	28	10	sign	sign	NOUN
dpc-2817	28	11	since	since	SCONJ
dpc-2817	28	12	it	it	PRON
dpc-2817	28	13	may	may	AUX
dpc-2817	28	14	be	be	AUX
dpc-2817	28	15	related	relate	VERB
dpc-2817	28	16	to	to	ADP
dpc-2817	28	17	a	a	DET
dpc-2817	28	18	poor	poor	ADJ
dpc-2817	28	19	prognosis	prognosis	NOUN
dpc-2817	28	20	.	.	PUNCT
dpc-2817	29	1	a	a	DET
dpc-2817	29	2	written	write	VERB
dpc-2817	29	3	consent	consent	NOUN
dpc-2817	29	4	form	form	NOUN
dpc-2817	29	5	signed	sign	VERB
dpc-2817	29	6	by	by	ADP
dpc-2817	29	7	the	the	DET
dpc-2817	29	8	patient	patient	NOUN
dpc-2817	29	9	has	have	AUX
dpc-2817	29	10	been	be	AUX
dpc-2817	29	11	obtained	obtain	VERB
dpc-2817	29	12	.	.	PUNCT
dpc-2817	30	1	2	2	NUM
dpc-2817	30	2	image	image	NOUN
dpc-2817	30	3	letter	letter	NOUN
dpc-2817	30	4	|	|	ADV
dpc-2817	30	5	dermatol	dermatol	ADJ
dpc-2817	30	6	pract	pract	NOUN
dpc-2817	30	7	concept	concept	NOUN
dpc-2817	30	8	.	.	PUNCT
dpc-2817	31	1	2023;13(2):e2023111	2023;13(2):e2023111	NUM
dpc-2817	31	2	references	reference	NOUN
dpc-2817	31	3	1	1	NUM
dpc-2817	31	4	.	.	PUNCT
dpc-2817	31	5	intapiboon	intapiboon	PROPN
dpc-2817	31	6	p	p	NOUN
dpc-2817	31	7	,	,	PUNCT
dpc-2817	31	8	siripaitoon	siripaitoon	PROPN
dpc-2817	31	9	b.	b.	PROPN
dpc-2817	31	10	erythematous	erythematous	ADJ
dpc-2817	31	11	auricular	auricular	ADJ
dpc-2817	31	12	papules	papule	NOUN
dpc-2817	31	13	in	in	ADP
dpc-2817	31	14	the	the	DET
dpc-2817	31	15	fatal	fatal	ADJ
dpc-2817	31	16	cases	case	NOUN
dpc-2817	31	17	of	of	ADP
dpc-2817	31	18	anti	anti	ADJ
dpc-2817	31	19	-	-	ADJ
dpc-2817	31	20	mda5	mda5	ADJ
dpc-2817	31	21	antibody	antibody	NOUN
dpc-2817	31	22	-	-	PUNCT
dpc-2817	31	23	positive	positive	ADJ
dpc-2817	31	24	interstitial	interstitial	ADJ
dpc-2817	31	25	lung	lung	NOUN
dpc-2817	31	26	disease	disease	NOUN
dpc-2817	31	27	.	.	PUNCT
dpc-2817	32	1	respir	respir	VERB
dpc-2817	32	2	med	med	ADJ
dpc-2817	32	3	case	case	NOUN
dpc-2817	32	4	rep	rep	PROPN
dpc-2817	32	5	.	.	PROPN
dpc-2817	32	6	2020;19;31:101299	2020;19;31:101299	NUM
dpc-2817	32	7	.	.	PUNCT
dpc-2817	33	1	doi	doi	NOUN
dpc-2817	33	2	:	:	PUNCT
dpc-2817	33	3	10.1016	10.1016	NUM
dpc-2817	33	4	/	/	SYM
dpc-2817	33	5	j.rmcr.2020.101299	j.rmcr.2020.101299	NOUN
dpc-2817	33	6	.	.	PUNCT
dpc-2817	34	1	pmid	pmid	NOUN
dpc-2817	34	2	:	:	PUNCT
dpc-2817	34	3	33294359	33294359	NUM
dpc-2817	34	4	.	.	PUNCT
dpc-2817	35	1	pmcid	pmcid	NOUN
dpc-2817	35	2	:	:	PUNCT
dpc-2817	35	3	pmc7695884	pmc7695884	PROPN
dpc-2817	35	4	.	.	PUNCT
dpc-2817	36	1	2	2	X
dpc-2817	36	2	.	.	X
dpc-2817	36	3	okiyama	okiyama	PROPN
dpc-2817	36	4	n	n	CCONJ
dpc-2817	36	5	,	,	PUNCT
dpc-2817	36	6	inoue	inoue	PROPN
dpc-2817	36	7	s	s	PROPN
dpc-2817	36	8	,	,	PUNCT
dpc-2817	36	9	saito	saito	PROPN
dpc-2817	36	10	a.	a.	PROPN
dpc-2817	36	11	et	et	PROPN
dpc-2817	36	12	al	al	PROPN
dpc-2817	36	13	.	.	PROPN
dpc-2817	37	1	antihelix	antihelix	ADJ
dpc-2817	37	2	/	/	SYM
dpc-2817	37	3	helix	helix	ADJ
dpc-2817	37	4	violaceous	violaceous	ADJ
dpc-2817	37	5	macules	macule	NOUN
dpc-2817	37	6	in	in	ADP
dpc-2817	37	7	japanese	japanese	ADJ
dpc-2817	37	8	patients	patient	NOUN
dpc-2817	37	9	with	with	ADP
dpc-2817	37	10	anti	anti	ADJ
dpc-2817	37	11	-	-	ADJ
dpc-2817	37	12	melanoma	melanoma	ADJ
dpc-2817	37	13	differentiation	differentiation	NOUN
dpc-2817	37	14	-	-	PUNCT
dpc-2817	37	15	associated	associate	VERB
dpc-2817	37	16	protein	protein	NOUN
dpc-2817	37	17	5	5	NUM
dpc-2817	37	18	(	(	PUNCT
dpc-2817	37	19	mda5	mda5	NOUN
dpc-2817	37	20	)	)	PUNCT
dpc-2817	37	21	antibody	antibody	NOUN
dpc-2817	37	22	-	-	PUNCT
dpc-2817	37	23	associated	associate	VERB
dpc-2817	37	24	dermatomyositis	dermatomyositis	NOUN
dpc-2817	37	25	.	.	PUNCT
dpc-2817	38	1	br	br	PROPN
dpc-2817	38	2	j	j	PROPN
dpc-2817	38	3	dermatol	dermatol	NOUN
dpc-2817	38	4	.	.	PUNCT
dpc-2817	39	1	2019;180(5):1226	2019;180(5):1226	NUM
dpc-2817	39	2	-	-	SYM
dpc-2817	39	3	1227	1227	NUM
dpc-2817	39	4	.	.	PUNCT
dpc-2817	40	1	doi	doi	NOUN
dpc-2817	40	2	:	:	PUNCT
dpc-2817	40	3	10.1111	10.1111	NUM
dpc-2817	40	4	/	/	SYM
dpc-2817	40	5	bjd.17431	bjd.17431	NOUN
dpc-2817	40	6	.	.	PUNCT
dpc-2817	41	1	pmid	pmid	NOUN
dpc-2817	41	2	:	:	PUNCT
dpc-2817	41	3	30431155	30431155	NUM
dpc-2817	41	4	.	.	PUNCT
dpc-2817	42	1	figure	figure	NOUN
dpc-2817	42	2	1	1	NUM
dpc-2817	42	3	.	.	PUNCT
dpc-2817	43	1	(	(	PUNCT
dpc-2817	43	2	a	a	PRON
dpc-2817	43	3	,	,	PUNCT
dpc-2817	43	4	b	b	NOUN
dpc-2817	43	5	)	)	PUNCT
dpc-2817	43	6	violaceous	violaceous	ADJ
dpc-2817	43	7	macules	macule	NOUN
dpc-2817	43	8	,	,	PUNCT
dpc-2817	43	9	crusting	crusting	NOUN
dpc-2817	43	10	and	and	CCONJ
dpc-2817	43	11	ulcers	ulcer	NOUN
dpc-2817	43	12	on	on	ADP
dpc-2817	43	13	both	both	DET
dpc-2817	43	14	auricles	auricle	NOUN
dpc-2817	43	15	.	.	PUNCT
dpc-2817	44	1	the	the	DET
dpc-2817	44	2	lesions	lesion	NOUN
dpc-2817	44	3	are	be	AUX
dpc-2817	44	4	more	more	ADV
dpc-2817	44	5	evident	evident	ADJ
dpc-2817	44	6	in	in	ADP
dpc-2817	44	7	anatomical	anatomical	ADJ
dpc-2817	44	8	protuberances	protuberance	NOUN
dpc-2817	44	9	such	such	ADJ
dpc-2817	44	10	as	as	ADP
dpc-2817	44	11	the	the	DET
dpc-2817	44	12	helix	helix	NOUN
dpc-2817	44	13	and	and	CCONJ
dpc-2817	44	14	antihelix	antihelix	NOUN
dpc-2817	44	15	.	.	PUNCT